Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fraudulent flu products

This article was originally published in The Gray Sheet

Executive Summary

FDA has so far issued more than 30 warning letters citing more than 70 products that have been fraudulently advertised as having a benefit for the H1N1 flu, according to FDA Acting Commissioner Joshua Sharfstein. To alert consumers about Web sites that are illegally marketing unapproved, uncleared or unauthorized products in relation to the H1N1 flu, FDA's consumer protection team has posted a list online, broken down into categories for: air systems, devices, gloves, kits, masks, sprays, supplements and tests. "The consumer protection team is quite active now looking at the Web to identify people who are really trying to defraud the American public," Sharfstein said on May 21 at a House Appropriations Committee Agriculture-FDA Subcommittee hearing on the President's fiscal 2010 FDA budget request. "My concern as a physician is that people would turn to products that clearly don't work instead of seeking medical attention," Sharfstein said
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027474

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel